| Literature DB >> 30894555 |
Aatira Vijay1, Prabhash Kumar Jha1, Iti Garg1, Manish Sharma1, Mohammad Zahid Ashraf1,2, Bhuvnesh Kumar3.
Abstract
MicroRNAs (miRNAs) are involved in a wide variety of cellular processes and post-transcriptionally regulate several mechanism and diseases. However, contribution of miRNAs functioning during hypoxia and DNA methylation together is less understood. The current study was aimed to find a shared miRNAs signature upstream to hypoxia (via HIF gene family members) and methylation (via DNMT gene family members). This was followed by the global validation of the hypoxia related miRNA signature using miRNA microarray meta-analysis of the hypoxia induced human samples. We further concluded the study by looking into thrombosis related terms and pathways enriched during protein-protein interaction (PPI) network analysis of these two sets of gene family. Network prioritization of these shared miRNAs reveals miR-129, miR-19band miR-23b as top regulatory miRNAs. A comprehensive meta-analysis of microarray datasets of hypoxia samples revealed 29 differentially expressed miRNAs. GSEA of the interacting genes in the DNMT-HIF PPI network indicated thrombosis associated pathways including "Hemostasis", "TPO signaling pathway" and "angiogenesis". Interestingly, the study has generated a novel database of candidate miRNA signatures shared between hypoxia and methylation, and their relation to thrombotic pathways, which might aid in the development of potential therapeutic biomarkers.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30894555 PMCID: PMC6426883 DOI: 10.1038/s41598-018-38057-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Workflow of analysis strategy. (A) Phase I- Workflow depicting the analysis strategy applied to uncover the shared miRNA candidate between HIF and DNMT gene families and subsequent analysis of the candidate miRNAs. (B) Phase II- Depiction of the flow chart of the process involved in global validation of phase I by integrated meta-analysis of the selected miRNA microarray datasets from the hypoxia exposed samples from human studies. (C) Phase III- Workflow depicting the analysis strategy for Interacting PPI network analysis of DNMT and HIF family genes to discern their association with thrombosis.
Figure 2Overrepresentation of Gene Ontology categories in Biological Networks identified from the list of target genes of shared miRNAs between HIF and DNMT family. (A) Enrichment network of shared DEGs based on biological processes. Significantly overrepresented biological processes based on GO terms were visualized in Cytoscape. The size of a node is proportional to the number of targets in the GO category. The color represents enrichment significance— the deeper the color on a color scale, the higher the enrichment significance. P-values were adjusted using a Benjamini and Hochberg False Discovery Rate (FDR) correction. (B) Table showing top five GO terms associated with the target genes. Overlap: indicates the number of hits from the meta-analysis compared to each curated gene set library; GO: gene ontology biological process.
Figure 3Hub shared miRNA and candidate prioritization. (A) Interaction network between shared miRNAs and target genes to perform hub miRNA analysis based on complex network centrality measures. The source nodes here are the miRNAs and target nodes are coding mRNAs (target genes), while the edges represent the interaction between them. The size and color of the nodes in network is relative to the betweenness centrality. The top hub miRNAs in the network are highlighted with bigger font size. (B) List of top hub miRNA selected from in silico analysis of miRNAs-mRNAs network based on scoring algorithm.
RNAfold analysis of miRNA-target genes interaction.
| Target Gene | Binding between target gene and miRNA | miRSVR score | Phastcons score | Min.Free Energy(kcal/mol) |
|---|---|---|---|---|
| miR-129-DNMT3A | 3′ cguucgggucuggc | −0.645 | 0.684 | −27.9 |
| miR-19b-DNMT3A | 3′ agucaaaacgUACCU | −0.104 | 0.787 | −25.8 |
| miR-19b-HIF1A | 3′ agUCAAAACGU –– ACCUA | −0.147 | 0.671 | −21.5 |
| miR-330-HIF1A | 3′ agagacguccggcac | −0.981 | 0.671 | −26.1 |
Table depicting miR binding site on DNMT and HIF1A, miRVR score by miRanda target prediction tool, binding energy and secondary binding structure were calculated using RNA HYBRID tool.
Characteristics of individual studies included in the miRNA meta-analysis of hypoxic exposure.
| S. No. | GEO accession no. | Platform of dataset | Samples(Ctl/exp) | No. of miRNAs | Organism | Sample source | Platform | Model of generating expression summaries | Reference |
|---|---|---|---|---|---|---|---|---|---|
| 1 | [GSE47532] | GPL8227 | (n = 11) 3/8 | 820 | Homo Sapiens | breast cancer cell line MCF-7 | Agilent-019118 Human miRNA Microarray 2.0 G4470B | log2 transformed and quantile normalized |
[ |
| 2 | [GSE60432 12 h] | GPL14550 | (n = 08) 4/4 | 851 | Homo Sapiens | human placental trophoblast cells | Agilent-028004 SurePrint G3 Human GE 8 × 60 K Microarray | log2 transformed and quantile normalized |
[ |
| [GSE60432 24 h] | GPL14550 | (n = 08) 4/4 | 851 | Homo Sapiens | human placental trophoblast cells | Agilent-028004 SurePrint G3 Human GE 8 × 60 K Microarray | log2 transformed and quantile normalized |
[ | |
| [GSE60432 48 h] | GPL14550 | (n = 08) 4/4 | 851 | Homo Sapiens | human placental trophoblast cells | Agilent-028004 SurePrint G3 Human GE 8 × 60 K Microarray | log2 transformed and quantile normalized |
[ | |
| [GSE60432 72 h] | GPL14550 | (n = 08) 4/4 | 851 | Homo Sapiens | human placental trophoblast cells | Agilent-028004 SurePrint G3 Human GE 8 × 60 K Microarray | log2 transformed and quantile normalized |
[ | |
| 3 | [GSE68593] | GPL20157 | (n = 06) 3/3 | 1907 | Homo Sapiens | Hepatocellular Carcinoma cells | Agilent-041686 Unrestricted Human miRNA Microarray | log2 transformed and quantile normalized |
[ |
GEO: Gene Expression Omnibus; GSE 60432 was further separated into four subgroups with 4/4 control and hypoxia exposed samples at different time points detailed in method section. These four subgroups were considered as individual datasets during meta-analysis. All the datasets used in this study were generated using a common platform; Agilent Human miRNA Microarray (probe name version).
Differentially expressed miRNAs identified in the meta-analysis.
| miRNAs | Individual dataset fold change | Meta-analysis results | ||||||
|---|---|---|---|---|---|---|---|---|
| GSE47532 | GSE68593 | GSE60431 12H | GSE60431 24H | GSE60431 48H | GSE60431 72H | CombinedTstat | CombinedPval | |
|
| ||||||||
| hsa-miR-210 | 0.45351 | 0.12816 | 0.607 | 1.246 | 2.4248 | 1.0887 | 128.68 | 0 |
| hsa-miR-483-3p | −0.02947 | 0.19988 | 0.076 | 0.25325 | 0.60175 | 0.25779 | 59.498 | 4.47E-06 |
| hsa-miR-361-3p | 0.13963 | 6.0635 | −0.0855 | −0.0035 | 0.0765 | 0.10783 | 55.075 | 1.88E-05 |
| hsa-miR-301b | −0.0681 | 5.7552 | −0.014 | 0.002 | 0.06125 | 0.18765 | 51.1 | 5.74E-05 |
| hsa-miR-342-3p | −0.01063 | 0.12554 | −0.02675 | 0.1645 | 0.56225 | 0.3065 | 46.993 | 2.50E-04 |
| hsa-miR-520d-3p | −0.0484 | 0 | 0.09075 | 0.11675 | 0.35225 | 0.073395 | 46.166 | 2.98E-04 |
| hsa-miR-339-3p | 0.058974 | 5.5948 | −0.02925 | 0.02625 | 0.05675 | 0.002168 | 42.961 | 6.69E-04 |
| hsa-miR-574-3p | 0.13376 | 0.11681 | 0.416 | 0.47175 | 0.57675 | 0.23595 | 37.716 | 0.003927 |
| hsa-miR-128 | −0.03101 | 0.092111 | −0.07125 | 0.11725 | 0.4125 | 0.22575 | 37.586 | 0.003927 |
| hsa-miR-520h | 0.041378 | 0 | 0.1005 | 0.0915 | 0.36925 | 0.098232 | 37.526 | 0.003927 |
| hsa-miR-519d | −0.01888 | 0 | 0.0715 | 0.241 | 0.321 | 0.063669 | 36.298 | 0.0051746 |
| hsa-miR-582-5p | −0.07989 | 0.44819 | −0.01475 | 0.10575 | −0.01625 | 0.11772 | 35.7 | 0.0061153 |
| hsa-miR-107 | 8.40E-04 | 0.040283 | 0.00775 | 0.04875 | 0.38475 | 0.10323 | 34.798 | 0.0080929 |
| hsa-miR-193a-5p | 0.10122 | 0 | 0.06075 | 0.16125 | 0.25325 | 0.13022 | 34.211 | 0.0095495 |
| hsa-miR-516a-5p | −0.0164 | 0 | 0.0855 | 0.1635 | 0.28775 | 0.032626 | 33.268 | 0.012717 |
| hsa-miR-34c-5p | 0.066224 | 0 | 0.19575 | 0.121 | 0.6915 | 0.53017 | 32.327 | 0.016476 |
| hsa-miR-501-5p | −0.03599 | 5.5245 | 0.30375 | −0.031 | 0.265 | −0.17533 | 32.068 | 0.01698 |
| hsa-miR-518b | −0.00666 | 0 | 0.08675 | 0.279 | 0.14625 | 0.060192 | 32.017 | 0.01698 |
| hsa-miR-887 | 0.22306 | 0 | 0.07125 | 0.271 | 0.63 | −0.04647 | 30.733 | 0.0248 |
| hsa-miR-28-5p | 0.01494 | 0.17883 | 0.083 | −0.03475 | 0.09975 | 0.13843 | 29.871 | 0.032319 |
|
| ||||||||
| hsa-miR-125a-3p | 0.060067 | −0.78435 | −0.17125 | −0.0925 | −0.30975 | −0.19433 | −30.783 | 0.0248 |
| hsa-miR-484 | 0.001933 | 0.26227 | −0.166 | −0.038 | −0.26975 | −0.16247 | −33.168 | 0.012717 |
| hsa-miR-140-5p | 0.089248 | 0.15487 | 0.0465 | −0.482 | −1.1058 | −0.32789 | −36.369 | 0.0051746 |
| hsa-miR-125a-5p | −0.0072 | 0.21208 | −0.381 | −0.9675 | −0.83275 | −0.12906 | −36.373 | 0.0051746 |
| hsa-miR-520b | 0.04912 | 0 | −0.239 | −0.2915 | −0.4175 | −0.11017 | −41.262 | 0.0011851 |
| hsa-miR-520f | −0.02961 | 0 | −0.32775 | −0.4665 | −0.74525 | −0.13725 | −43.872 | 5.15E-04 |
| hsa-miR-372 | 0.035251 | 0 | −0.26925 | −0.71425 | −1.1938 | −0.37945 | −44.681 | 4.17E-04 |
| hsa-miR-516a-3p | −0.00785 | 0 | −0.26275 | −0.36675 | −0.75625 | −0.23978 | −45.089 | 3.99E-04 |
| hsa-miR-520c-3p | 0.017946 | 0 | −0.354 | −0.666 | −0.80975 | −0.10691 | −52.649 | 3.82E-05 |
Genes were ranked based according to the combined Tstat. List was generated by combining p-val (Fisher’s method) combination which takes into consideration both the direction and magnitude of gene expression changes. The table shows expression value of particular DE miRNA in both the individual data and the meta-analysis results.
Figure 4miRNA expression pattern of the hypoxia induced samples from meta-analysis. (A) Heat-map representation of expression profiles for the differentially expressed miRNA obtained from meta-analysis. Clustering of selected genes on the heat-map was performed by hierarchical clustering algorithm using Euclidean distance measure. Class 1 (Red): Control samples; Class 2 (Blue): Hypoxia exposed samples. (B) Venn diagram of differentially expressed miRNAs identified from the meta-analysis (Meta-DE) and those from each individual microarray analysis (Individual-DE). (C) Chord diagram showing the differentially expressed miRNAs connection between the individual datasets and the meta-data.
Figure 5Interacting PPI network analysis of DNMT and HIF family genes. (A) Zero-order interaction network of shared DEGs obtained from meta-analysis using force-directed algorithm with minimum overlap layout (B) PPI Subnetwork of proteins associated with DNMT family genes (C) PPI Subnetwork of proteins associated with HIF1A. The subnetworks were drawn using the module extractor tool of NetworkAnalyst.
Top thrombosis related pathway obtained from the enrichment analysis of the genes associated with the interacting PPI of the HIF and DNMT family genes.
| GSEA | Pathway/Term ID | Overlap | Associated genes | GSEA library | AdjP-value |
|---|---|---|---|---|---|
|
| |||||
| Hemostasis | R-HSA-109582 | 33/552 | APP;HDAC2;SPARC;KDM1A;SHC1;SRC;HDAC1;SERPINE1; | Reactome | 7.19E-08 |
| Angiogenesis | P00005 | 13/142 | GSK3B;JUN;NOTCH1;SHC1;NOS3;SRC;STAT3;ETS1; | Panther | 2.52E-05 |
| NF-kappa B signaling pathway | hsa04064 | 10/93 | PIAS4;UBE2I;CSNK2A1;PARP1;CSNK2B;BCL2; | KEGG | 5.11342E-05 |
| VEGF, Hypoxia, and Angiogenesis | h_vegfPathway | 08/302 | HSP90AA1;NOS3;SRC;SHC1;ARNT;AKT1;VHL;VEGFA | Biocarta | 6.10235E-07 |
| TPO Signaling Pathway | h_TPOPathway | 05/42 | STAT5A;JUN;CSNK2A1;SHC1;STAT3 | Biocarta | 0.000280854 |
List of top thrombosis associated pathways along with its related genes and the GSEA library from which the term was obtained.